Tocilizumab for the Management of Osimertinib-Induced Pneumonitis in a Critically Ill Patient
JCO Precision Oncology · 2026-05 · 10 (5)
DOI: 10.1200/po-25-01280 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2026-05. Verfasst von Caroline Hénin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Critical Care Department, Saint-Luc University Hospital, Bruxelles, Belgium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Critical Care Department, Saint-Luc University Hospital, Bruxelles, Belgium.
- Critical Care Department, Saint-Luc University Hospital, Université Catholique de Louvain, IREC, Bruxelles, Belgium.
- Rhumatology Department, Saint-Luc University Hospital, Bruxelles, Belgium.
- Pneumology Department, Saint-Luc University Hospital, Bruxelles, Belgium.
ORCID-Profile: Ludovic Gerard, João Pinto Pereira
Zitieren
APA
Hénin, C., Gerard, L., Werion, A., Tamirou, F., Aboubakar, F., Montiel, V., & Pinto Pereira, J. (2026). Tocilizumab for the Management of Osimertinib-Induced Pneumonitis in a Critically Ill Patient. JCO Precision Oncology, 10(5). https://doi.org/10.1200/po-25-01280
Vancouver
Hénin C, Gerard L, Werion A, Tamirou F, Aboubakar F, Montiel V, et al. Tocilizumab for the Management of Osimertinib-Induced Pneumonitis in a Critically Ill Patient. JCO Precision Oncology. 2026;10(5). doi:10.1200/po-25-01280
BibTeX
@article{Hnin2026,
author = {Hénin, Caroline and Gerard, Ludovic and Werion, Alexis and Tamirou, Farah and Aboubakar, Frank and Montiel, Virginie and Pinto Pereira, João},
title = {Tocilizumab for the Management of Osimertinib-Induced Pneumonitis in a Critically Ill Patient},
journal = {JCO Precision Oncology},
year = {2026},
volume = {10},
number = {5},
doi = {10.1200/po-25-01280}
}
EUVIMED